Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.41
-0.13 (-1.99%)
May 12, 2026, 4:08 PM HKT

HKG:0719 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
10,0909,7709,28211,89717,7406,846
Market Cap Growth
18.54%5.26%-21.98%-32.94%159.15%25.67%
Enterprise Value
10,53410,34710,08312,70617,7088,175
Last Close Price
6.546.595.575.237.093.95
PE Ratio
14.9130.2918.5621.7538.1716.00
PS Ratio
1.011.001.031.332.090.85
PB Ratio
1.591.611.672.263.611.53
P/TBV Ratio
1.851.901.972.664.301.86
P/FCF Ratio
28.2021.0056.20-30.56563.90
P/OCF Ratio
21.7216.4523.7340.7120.7021.52
EV/Sales Ratio
1.061.061.121.422.091.01
EV/EBITDA Ratio
9.809.859.0311.2416.457.93
EV/EBIT Ratio
26.7825.9918.5622.5233.6216.50
EV/FCF Ratio
29.4422.2461.05-30.51673.39
Debt / Equity Ratio
0.250.270.320.280.320.45
Debt / EBITDA Ratio
1.501.571.581.321.451.95
Debt / FCF Ratio
4.513.5410.74-2.70166.46
Net Debt / Equity Ratio
0.030.020.080.090.050.25
Net Debt / EBITDA Ratio
0.150.090.400.430.241.07
Net Debt / FCF Ratio
0.460.202.72-7.360.4491.16
Asset Turnover
0.950.960.980.980.960.91
Inventory Turnover
5.995.535.014.584.934.48
Quick Ratio
1.180.930.850.760.680.65
Current Ratio
1.761.441.331.331.091.10
Return on Equity (ROE)
4.99%5.74%9.74%11.09%10.65%10.28%
Return on Assets (ROA)
2.35%2.46%3.69%3.87%3.73%3.50%
Return on Invested Capital (ROIC)
5.00%5.46%8.58%9.94%9.22%7.95%
Return on Capital Employed (ROCE)
5.10%5.60%8.20%8.80%9.10%8.40%
Earnings Yield
2.95%3.30%5.39%4.60%2.62%6.25%
FCF Yield
3.55%4.76%1.78%-0.55%3.27%0.18%
Dividend Yield
2.64%2.53%5.26%5.27%3.19%4.66%
Payout Ratio
82.50%72.37%48.05%35.43%39.66%42.59%
Buyback Yield / Dilution
3.76%-0.50%0.54%-3.20%-6.93%0.02%
Total Shareholder Return
6.54%2.04%5.80%2.07%-3.74%4.68%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.